Relapse after exclusively surgical treatment of Mycobacterium ulcerans infection (Buruliulcer): Study of risk factors in 84 congolese patients;Rechutes après traitement chirurgical exclusif de l'infection à Mycobacterium ulcerans (ulcère de Buruli): Étude des facteurs de risque chez 84 patients congolais

Medecine Tropicale

Volumn 69, Issue 5, 2009, Pages 471-474

  Kibadi, K ^a,b,c,d   Mputu Yamba, J B ^a   Mokassa, B ^a   Panda, M ^a   Muyembe Tamfum, J J ^b  

^a cliniques universitaires de Kinshasa   (Democratic Republic Congo)

^b Institut National de Recherche Biomedicale INRB   (Democratic Republic Congo)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Buruli ulcer; Democratic Republic of Congo; Mycobacterium ulcerans; Surgery

Indexed keywords

ARTICLE; BURULI ULCER; CONGO; EDEMA; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; SURGICAL TECHNIQUE; TREATMENT RESPONSE; ADOLESCENT; AGE; DEMOCRATIC REPUBLIC CONGO; FEMALE; MALE; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; AGE FACTORS; BURULI ULCER; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HUMANS; MALE; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 75349108947     PISSN: 0025682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. World Health Organization (WHO) - Buruli ulcer: progress report, 2004-2008. Weekly Epidemiol Rec 2008; 83 : 145-56.
2. Portaels F, Silva MT, Meyers WM. Buruli ulcer. Clin Dermatol 2009; 27 : 291-305.
3. Molyneux DH, Hotez PJ, Fenwick A. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. Plos Medicine 2005; 2 : e336.
4. Aguiar J, Steunou C. Les ulcères de Buruli en zone rurale au Bénin: prise en charge de 635 cas. Med Trop 1997; 57 : 83-96.
5. Ouattara D, Meningaud JP, Kaba L, Sica A, Assé H. Traitement de l'ulcère de Buruli par excision-greffe: à propos de 118 observations. Ann Chir Plast Esthet 2004; 49 : 11-6. (Pubitemid 38338517)
6. Wold Health Organization. Surgical treatment. In "Buntine J, Crofts K. Buruli ulcer. Management of Mycobacterium ulcerans disease". WHO ed, Geneva, 2001, pp 28-40.
7. van der Werf TS, van der Graaf WT, Groothuis DG, Knell AJ. Mycobacterium ulcerans infection in Ashanti region, Ghana. Trans R Soc Trop Med Hyg 1989; 83 : 410-3. (Pubitemid 19163238)
8. Kanga JM, Kacou DE, Sangaré A, Dabila Y, Asse NH, Djakeaux S. Les rechutes observées après le traitement chirurgical des cas d'ulcères de Buruli en Côte d'Ivoire. Bull Soc Pathol Exot 2003; 96 : 406-9. (Pubitemid 38283295)
9. Kibadi AK. Les rechutes après traitement de l'ulcère de Buruli par la chirurgie en Afrique. Bull Soc Pathol Exot 2006; 99 : 230-5. (Pubitemid 44935713)
10. Wold Health Organization (WHO) - Provisional guidance on the role of specific antibiotic in the management of Mycobacterium ulcerans disease (Buruli ulcer). WHO/CDS/CPE/GBUI/2004, WHO, Geneva, 33p.
11. Kibadi K. Ulcère à Mycobacterium ulcerans: prise en charge chirurgicale dans 102 observations en République Démocratique du Congo. Med Trop 2005; 65 : 444-8.
12. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Portaels F. Buruli ulcer recurrence, Benin. Emerg infect Dis 2005; 11 : 584-9. (Pubitemid 40462909)
13. World Health Organization. Buruli Ulcer. Diagnosis of Mycobacterium ulcerans disease. In "Portaels F, Johnson P, Meyers WM. A manual for health care providers". WHO ed, Geneva, 2001, 92 p.
14. Cornet L, Richard-Kadio M, N'Guessan HA, Yapo P, Hossoko H, Dick R et al. Le traitement des ulcères de Buruli par excision-greffe. Bull Soc Path Exot 1992; 85: 355-8.
15. O'Brien DP, Hughes AJ, Cheng AC, Henry MJ, Callan P, McDonald A et al. Outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south-eastern Australian case series. Med J Aust 2007; 186 : 58-61. (Pubitemid 46178815)
16. Teelken MA, Stienstra Y, Ellen DE, Quarshie E, Klutse E, van der Graaf WT et al. Buruli ulcer: differences in treatment outcome between two centres in Ghana. Acta Trop 2003; 88 : 51-6. (Pubitemid 37013336)
17. Bretzel G, Siegmund V, Racz P, van Vloten F, Ngos F, Thompson W et al. Post-surgical assessment of excised tissue from patients with Buruli ulcer disease: progression of infection in macroscopically healthy tissue. Trop Med Int Health 2005; 10 : 1199-206. (Pubitemid 41641200)
18. Rondini S, Mensah-Quainoo E, Junghanss T, Pluschke G. What does detection of Mycobacterium ulcerans DNA in the margin of an excised Buruli ulcer lesion tell us? J Clin Microbiol 2006; 44 : 4273-5. (Pubitemid 44737291)
19. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Scott JT et al. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 2004; 9 : 1297-304. (Pubitemid 40037165)
20. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Guédénon A et al. Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997-2001. Emerg infect Dis 2004; 10 : 1391-8. (Pubitemid 39014151)
21. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R et al. Effacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 2005; 49 : 3182-6. (Pubitemid 41060558)
22. Chauty A, Ardant MF, Adeye A, Euverte H, Guédénon A, Johnson RC et al. Promising clinical efficacy of streptomycin-rifampin combination for treatment of Buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 2007; 51 : 4029-35. (Pubitemid 350057802)
23. Dossou AD, Sopoh GE, Johnson CR, Barogui YT, Affolabi D, Anagonou SY et al. Management of Mycobacterium ulcerans infection in a pregnant woman in Benin using rifampicin and clarithromycin. Med J Aust 2008; 189 : 532-3.